Home > Products > Antibodies > Bispecific Antibodies

Research Grade Tibulizumab (HS856106)

Price(USD): $

Spec:

100ug
1mg

Number:

Contact us

Overview
Images
References
Datasheet

Overview

Catalog No.	HS856106
Species reactivity	Human
Applications	Research Grade Biosimilar
Host species	Humanized
Isotype	IgG4-kappa-[scFv]2
Expression system	Mammalian Cells
Species	Human
Clonality	Monoclonal
Target	CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor
Concentration	0.71 mg/ml
Endotoxin level	Please contact with the lab for this information.
Purity	>95% as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	Q16552 & Q9Y275
Form	Liquid
Storage buffer	0.01M PBS, pH 7.4.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names	Bispecific, LY 3090106, LY-3090106, LY3090106, CAS: 1849636-24-3
Note	For research use only. Not suitable for clinical or therapeutic use.

Images

SDS-PAGE

SDS-PAGE for Research Grade Tibulizumab
Bioactivity

Detects Human IL17A in direct ELISAs.

References

HS856106-SDS-PAGE-1.jpg

Datasheet

Research Grade Tibulizumab.pdf

Recommendation

Tibulizumab ELISA Kit

Research Grade Tibulizumab